 |
|
|
| |
Effectiveness of Elbasvir/Grazoprevir in
Black Persons With Genotype 1 Hepatitis C Virus
|
| |
| |
Reported by jules Levin
AASLD 2018 Nov 9-12 Boston
Jennifer R. Kramer1,2; Amy Puenpatom3; Yumei Cao1; Hashem El-Serag1,2; Fasiha Kanwal1,2
1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical
Center, Houston, TX, USA; 2Department of Medicine, Baylor College of Medicine, Houston, TX, USA;
3Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
